Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00278135 · ClinicalTrials.gov registry record · NA
Memory Improvement With Docosahexaenoic Acid Study (MIDAS)
A NA study, sponsored by dsm-firmenich Switzerland.
- Completed
- Registry status
- NA
- Development phase
- 485
- Enrollment target
NCT00278135: Completed NA study, sponsored by dsm-firmenich Switzerland.
NCT00278135 is a NA study that has completed, run by dsm-firmenich Switzerland. The registered enrollment target is 485 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00278135, a NA study, has completed, sponsored by dsm-firmenich Switzerland.
- COMPLETED
- Registry status
- NA
- Development phase
- 485 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effect of docosahexaenoic acid (DHA, 22:6n-3) in improving cognitive functions in subjects with age-related cognitive decline. DHA is a long chain omega-3 fatty acid (LC-PUFA) that plays an important role in neural and visual development and cardiovascular health.
Interventions
- DIETARY_SUPPLEMENT DHA (nutritional supplement) or placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 485 participants |
| Start Date | 2005-12 |
| Est. Completion | 2008-12 |
| Phase | NA |
What the finished NCT00278135 record still lists
NCT00278135 is an interventional study that assigns participants to a tested intervention. The registered 485 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 1 intervention - of which DHA (nutritional supplement) or placebo is the first listed.
NCT00278135 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00278135 about?
NCT00278135 is a clinical study titled "Memory Improvement With Docosahexaenoic Acid Study (MIDAS)". The purpose of this study is to investigate the effect of docosahexaenoic acid (DHA, 22:6n-3) in improving cognitive functions in subjects with age-related cognitive decline. DHA is a long chain omega-3 fatty acid (LC-PUFA) that plays an important role in neural and visual development and cardiovasc...
What is the current status of trial NCT00278135?
This trial is currently completed. It is a NA study. The enrollment target is 485 participants. The study started on 2005-12. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00278135?
The interventions under investigation include: DHA (nutritional supplement) or placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00278135?
This trial is sponsored by dsm-firmenich Switzerland, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00278135's enrollment target sits among peer trials
485 216th of 2000 higher than 1,785 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07124910 · 485 participants · Phase 3
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
- NCT06420531 · 486 participants · NA
Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial
- NCT07097142 · 486 participants · Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia